Cargando…

Inflammatory Response and Toxicity After Pressurized IntraPeritoneal Aerosol Chemotherapy

Background: Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) is a novel mode of intraperitoneal (IP) drug delivery claiming high IP tissue concentrations with low systemic uptake. The aim was to study inflammatory response and systemic toxicity after PIPAC. Methods: Retrospective monocentric...

Descripción completa

Detalles Bibliográficos
Autores principales:	Teixeira Farinha, Hugo, Grass, Fabian, Labgaa, Ismaïl, Pache, Basile, Demartines, Nicolas, Hübner, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743707/ https://www.ncbi.nlm.nih.gov/pubmed/29290765 http://dx.doi.org/10.7150/jca.21460

Ejemplares similares

Feasibility and Safety of Pressurized Intraperitoneal Aerosol Chemotherapy for Peritoneal Carcinomatosis: A Retrospective Cohort Study
por: Hübner, Martin, et al.
Publicado: (2017)

Anaesthesia in a Toxic Environment: Pressurised Intraperitoneal Aerosol Chemotherapy: A Retrospective Analysis
por: Rouche, Amir, et al.
Publicado: (2020)

Impact of Pressurized Intraperitoneal Aerosol Chemotherapy on Quality of Life and Symptoms in Patients with Peritoneal Carcinomatosis: A Retrospective Cohort Study
por: Teixeira Farinha, Hugo, et al.
Publicado: (2017)

Early postoperative outcomes of staging laparoscopy for peritoneal metastases with or without pressurized intra-peritoneal aerosol chemotherapy (PIPAC)
por: Teixeira Farinha, Hugo, et al.
Publicado: (2022)

Treatment Response After Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Metastases of Colorectal Originf
por: Hübner, Martin, et al.
Publicado: (2022)

Selection Criteria for Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Treatment in Patients with Peritoneal Metastases
por: Balmer, Aurélie, et al.
Publicado: (2022)

The role of cytology in patients undergoing pressurized intraperitoneal aerosol chemotherapy (PIPAC) treatment for peritoneal carcinomatosis
por: Deban, Mélina, et al.
Publicado: (2023)

Assessment of Treatment Response after Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) for Appendiceal Peritoneal Metastases
por: Somashekhar, SP, et al.
Publicado: (2022)

Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) as an outpatient procedure
por: Graversen, Martin, et al.
Publicado: (2018)

Histological regression of peritoneal metastases of recurrent tubo-ovarian cancer after systemic chemotherapy
por: Pache, Basile, et al.
Publicado: (2022)

Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) for the treatment of malignant mesothelioma
por: Giger-Pabst, Urs, et al.
Publicado: (2018)

Treatment of peritoneal carcinomatosis with Pressurized IntraPeritoneal Aerosol Chemotherapy – PIPAC-OPC2
por: Graversen, Martin, et al.
Publicado: (2018)

Response Evaluation in Patients with Peritoneal Metastasis Treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)
por: Roensholdt, Signe, et al.
Publicado: (2023)

Comparison between microcatheter and nebulizer for generating Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)
por: Toussaint, Laura, et al.
Publicado: (2020)

Radiologist Checklist for Selecting Patients to Undergo PIPAC (Pressurized IntraPeritoneal Aerosol Chemotherapy)
por: Rodolfino, Elena, et al.
Publicado: (2021)

Staging laparoscopy and Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) for peritoneal metastasis: safe access to the abdomen
por: Glatz, Torben, et al.
Publicado: (2019)

Bidirectional treatment of peritoneal metastasis with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) and systemic chemotherapy: a systematic review
por: Ploug, Magnus, et al.
Publicado: (2020)

The role of Pressurized IntraPeritoneal Aerosol Chemotherapy in the management of gastric cancer: A systematic review
por: Garg, Pankaj Kumar, et al.
Publicado: (2019)

Correction to: Comparison between microcatheter and nebulizer for generating Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)
por: Toussaint, Laura, et al.
Publicado: (2021)

Anaesthesia considerations and techniques for Pressurised IntraPeritoneal Aerosol Chemotherapy (PIPAC)
por: Shree, Venkatesan, et al.
Publicado: (2020)

Reasons for stopping Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC): A retrospective study to improve future patient selection
por: Ezanno, Anne-Cécile, et al.
Publicado: (2023)

Histological regression of gastrointestinal peritoneal metastases after systemic chemotherapy
por: Toussaint, Laura, et al.
Publicado: (2021)

Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)-directed treatment of peritoneal metastasis in end-stage colo-rectal cancer patients
por: Ellebæk, Signe Bremholm, et al.
Publicado: (2020)

Is Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) Effective in Ovarian Cancer With Peritoneal Metastasis?
por: Mohammad, Amad, et al.
Publicado: (2022)

Renal and Hepatic Toxicities After Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)
por: Blanco, Ana, et al.
Publicado: (2013)

Consensus statement on safety measures for pressurized intraperitoneal aerosol chemotherapy
por: Girardot-Miglierina, Arnaud, et al.
Publicado: (2021)

Pressurized intraperitoneal aerosol chemotherapy procedure for nonresectable peritoneal carcinomatosis: First Indian study
por: Somashekhar, S. P., et al.
Publicado: (2019)

Preoperative Nutritional Conditioning of Crohn’s Patients—Systematic Review of Current Evidence and Practice
por: Grass, Fabian, et al.
Publicado: (2017)

Correlation of postoperative fluid balance and weight and their impact on outcomes
por: Butti, Fabio, et al.
Publicado: (2020)

Effect of Liposomal Doxorubicin in Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC)
por: Mikolajczyk, Agata, et al.
Publicado: (2018)

Pressurized IntraPeritoneal Aerosol Chemotherapy vs. intravenous chemotherapy for unresectable peritoneal metastases secondary to platinum resistant ovarian cancer – study protocol for a randomized control trial
por: Somashekhar, S. P., et al.
Publicado: (2019)

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Low-Dose Cisplatin and Doxorubicin in Gastric Peritoneal Metastasis
por: Nadiradze, Giorgi, et al.
Publicado: (2015)

Feasibility of pressurized intra peritoneal aerosol chemotherapy using an ultrasound aerosol generator (usPIPAC)
por: Höltzcke, Phil, et al.
Publicado: (2022)

Pressurized Intra Peritoneal Aerosol Chemotherapy in patients suffering from peritoneal carcinomatosis of pancreatic adenocarcinoma
por: Khosrawipour, Tanja, et al.
Publicado: (2017)

Intraperitoneal Chemotherapy of Peritoneal Carcinomatosis Using Pressurized Aerosol as an Alternative to Liquid Solution: First Evidence for Efficacy
por: Solass, Wiebke, et al.
Publicado: (2013)

Prospective, single-center implementation and response evaluation of pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastasis
por: Graversen, Martin, et al.
Publicado: (2018)

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Metastases in Solid Organ Graft Recipients: First Experience
por: Horvath, Philipp, et al.
Publicado: (2019)

Feasibility, Safety, and Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Metastasis: A Registry Study
por: Kurtz, Florian, et al.
Publicado: (2018)

Establishment of a rat ovarian peritoneal metastasis model to study pressurized intraperitoneal aerosol chemotherapy (PIPAC)
por: Van de Sande, Leen, et al.
Publicado: (2019)

Pressurized intraperitoneal aerosol chemotherapy with cisplatin and doxorubicin or oxaliplatin for peritoneal metastasis from pancreatic adenocarcinoma and cholangiocarcinoma
por: Di Giorgio, Andrea, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kg8e888f4n6hodsi693duc7lc0